相似文献
1
The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity.
Mol Immunol. 2011 Jun;48(11):1319-27. doi: 10.1016/j.molimm.2010.12.005. Epub 2011 Jan 13.
2
ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.
J Exp Med. 2010 Mar 15;207(3):623-35. doi: 10.1084/jem.20091990. Epub 2010 Feb 15.
3
The emerging role of ADAM metalloproteinases in immunity.
Nat Rev Immunol. 2018 Dec;18(12):745-758. doi: 10.1038/s41577-018-0068-5.
4
A disintegrin and metalloproteinase 10 regulates antibody production and maintenance of lymphoid architecture.
J Immunol. 2011 Nov 15;187(10):5114-22. doi: 10.4049/jimmunol.1102172. Epub 2011 Oct 12.
5
The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity.
J Immunol. 2015 Jan 15;194(2):542-52. doi: 10.4049/jimmunol.1402070. Epub 2014 Dec 10.
6
ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23.
Nat Immunol. 2006 Dec;7(12):1293-8. doi: 10.1038/ni1399. Epub 2006 Oct 29.
7
Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
Mol Immunol. 2015 Jun;65(2):416-28. doi: 10.1016/j.molimm.2015.02.008. Epub 2015 Mar 5.
8
ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch.
J Immunol. 2011 Apr 1;186(7):4244-52. doi: 10.4049/jimmunol.1003318. Epub 2011 Mar 2.
9
CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.
J Biol Chem. 2010 Nov 26;285(48):37531-41. doi: 10.1074/jbc.M110.141556. Epub 2010 Sep 28.
10
ADAM10 regulates Notch function in intestinal stem cells of mice.
Gastroenterology. 2014 Oct;147(4):822-834.e13. doi: 10.1053/j.gastro.2014.07.003. Epub 2014 Jul 16.
引用本文的文献
1
Immune dysfunction during S. aureus biofilm-associated implant infections: opportunities for novel therapeutic strategies.
NPJ Biofilms Microbiomes. 2025 Jul 25;11(1):144. doi: 10.1038/s41522-025-00782-y.
2
Circ_0088194 Regulates Proliferation, Migration, Apoptosis, and Inflammation by miR-30a-3p/ADAM10 Axis in Rheumatoid Arthritis Fibroblastic Synovial Cells.
Inflammation. 2023 Feb;46(1):161-174. doi: 10.1007/s10753-022-01719-9. Epub 2022 Aug 2.
3
ADAM10 Site-Dependent Biology: Keeping Control of a Pervasive Protease.
Int J Mol Sci. 2021 May 7;22(9):4969. doi: 10.3390/ijms22094969.
4
Genomic Signatures of Coevolution between Nonmodel Mammals and Parasitic Roundworms.
Mol Biol Evol. 2021 Jan 23;38(2):531-544. doi: 10.1093/molbev/msaa243.
5
Editorial: ADAM10 in Cancer Immunology and Autoimmunity: More Than a Simple Biochemical Scissor.
Front Immunol. 2020 Jul 16;11:1483. doi: 10.3389/fimmu.2020.01483. eCollection 2020.
6
Targeting ADAM10 in Cancer and Autoimmunity.
Front Immunol. 2020 Mar 24;11:499. doi: 10.3389/fimmu.2020.00499. eCollection 2020.
7
Stage-dependent involvement of ADAM10 and its significance in epileptic seizures.
J Cell Mol Med. 2019 Jul;23(7):4494-4504. doi: 10.1111/jcmm.14307. Epub 2019 May 13.
8
A Role for Soluble IL-6 Receptor in Osteoarthritis.
J Funct Morphol Kinesiol. 2017;2(3). doi: 10.3390/jfmk2030027. Epub 2017 Aug 2.
9
Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein.
Oncotarget. 2016 Oct 25;7(43):70092-70099. doi: 10.18632/oncotarget.11780.
10
The ADAMs family of proteases as targets for the treatment of cancer.
Cancer Biol Ther. 2016 Aug 2;17(8):870-80. doi: 10.1080/15384047.2016.1177684. Epub 2016 Apr 26.
本文引用的文献
1
CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.
J Biol Chem. 2010 Nov 26;285(48):37531-41. doi: 10.1074/jbc.M110.141556. Epub 2010 Sep 28.
2
ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.
J Exp Med. 2010 Mar 15;207(3):623-35. doi: 10.1084/jem.20091990. Epub 2010 Feb 15.
3
Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.
Blood. 2010 Mar 4;115(9):1735-45. doi: 10.1182/blood-2009-07-235143. Epub 2009 Dec 9.
4
Metalloprotease ADAM10 is required for Notch1 site 2 cleavage.
J Biol Chem. 2009 Nov 6;284(45):31018-27. doi: 10.1074/jbc.M109.006775. Epub 2009 Sep 2.
5
Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
Mol Cell Biol. 2009 Nov;29(21):5679-95. doi: 10.1128/MCB.00406-09. Epub 2009 Aug 24.
6
TLR4-mediated signaling induces MMP9-dependent cleavage of B cell surface CD23.
J Immunol. 2009 Aug 15;183(4):2585-92. doi: 10.4049/jimmunol.0803660. Epub 2009 Jul 27.
7
ADAM10 as a therapeutic target for cancer and inflammation.
Curr Pharm Des. 2009;15(20):2288-99. doi: 10.2174/138161209788682442.
8
Notch ligands expressed by follicular dendritic cells protect germinal center B cells from apoptosis.
J Immunol. 2009 Jul 1;183(1):352-8. doi: 10.4049/jimmunol.0803183.
9
Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation.
J Immunol. 2009 Jun 15;182(12):7381-8. doi: 10.4049/jimmunol.0804322.
10
Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma.
Cancer Sci. 2009 May;100(5):920-6. doi: 10.1111/j.1349-7006.2009.01130.x.
Zotero 插件